Abstract
BackgroundMalaria/HIV co-infection (MHC) is a public health challenge which may present with worse health outcomes due to interactions. Coadministration of artemether lumefantrine (ALU) and antiretroviral therapy may have potential drug-drug...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have